We focus on discovering and advancing new treatments for serious patient needs. From the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
Our Immuno-oncology research program aims to treat most human cancers with immune therapy.
The infectious diseases research team searches for novel therapies for major bacterial and viral infections for which current therapies are lacking or suboptimal. Current work focuses on multidrug-resistant, Gram-negative bacterial pathogens, several important respiratory viruses, chronic hepatitis B, and certain virus-associated malignancies.
The Novartis Institute for Tropical Diseases is a drug discovery research institute dedicated to finding novel treatments for neglected tropical diseases, including malaria, cryptosporidiosis, and three major kinetoplastid diseases – human African trypanosomiasis, Chagas disease, and leishmaniasis.